US2021171507A1PendingUtilityA1
Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
Est. expiryJul 16, 2021(expired)· nominal 20-yr term from priority
A61P 35/00C07D 295/185A61P 27/02A61P 25/28A61P 1/16A61K 31/4025C07D 405/06C07D 319/18C07D 498/04A61P 43/00A61P 17/02A61P 3/00A61P 7/06
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose:N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.
Claims
exact text as granted — not AI-modified1 - 23 . (canceled)
24 . A method of preparing a compound of formula (2)
said method comprising reacting a compound of formula (1)
with pyrrolidine, followed by hydrolysis.
25 . The method of claim 24 , wherein the hydrolysis is carried out using methanol as solvent.
26 . The method of claim 24 , wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde.
27 . The method of claim 26 , wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i)
with a compound of formula (ii)
28 . The method of claim 24 , further comprising reducing the compound of formula (2) to form a compound of formula (3)
29 . The method of claim 28 , wherein the reduction is carried out using lithium aluminum hydride.
30 . A method of preparing a compound of formula (3)
said method comprising reducing a compound of formula (2)
31 . The method of claim 30 , wherein the reduction is carried out using lithium aluminum hydride.
32 . The method of claim 30 , wherein the compound of formula (2) is prepared by reacting a compound of formula (1)
with pyrrolidine, followed by hydrolysis.
33 . The method of claim 32 , wherein the hydrolysis is carried out using methanol as solvent.
34 . The method of claim 32 , wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde.
35 . The method of claim 34 , wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i)
with a compound of formula (ii)Join the waitlist — get patent alerts
Track US2021171507A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.